Amlodipine Besylate Tablet
Product Images NDC 60687-488

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 60687-488). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg Amlodipine Besylate Tablet Blister (10 mg Amlodipine Besylate Tablet Blister)

A sheet of multiple labels for Amlodipine Besylate 10 mg tablets, oral dosage form, from American Health Packaging. Each label includes the drug name, strength (10 mg), barcode, lot number, and expiry date placeholders. The labels are arranged in a grid format for printing or application.*

FDA Label Image

10 mg Amlodipine Besylate Tablets Carton (10 mg Amlodipine Besylate Tablets Carton)

Amlodipine Besylate 10 mg tablets label showing 100 tablets (10 x 10) in USP strength. The label includes NDC 60687-496-01, marked Rx Only, and states that each tablet contains amlodipine besylate equivalent to 10 mg of amlodipine. It also provides storage instructions, safety warnings, and packaging information by American Health Packaging, Columbus, Ohio.*

FDA Label Image

2.5 mg Amlodipine Besylate Tablet Blister (2.5 mg Amlodipine Besylate Tablet Blister.jpg)

A sheet of multiple medication labels for Amlodipine Besylate tablet, USP, 2.5 mg strength. Each label includes the drug name, strength, dosage form, bar code, lot number, expiration date, and the labeler American Health Packaging, Columbus, Ohio.*

FDA Label Image

2.5 mg Amlodipine Besylate Tablets Carton (2.5 mg Amlodipine Besylate Tablets Carton.jpg)

Label for Amlodipine Besylate tablets USP, 2.5 mg strength. The package contains 100 tablets (10 x 10) for oral use. The label includes dosing equivalence information and storage instructions, and it identifies American Health Packaging as the distributor and Ascend Laboratories as the drug product manufacturer.*

FDA Label Image

5 mg Amlodipine Besylate Tablet Blister (5 mg Amlodipine Besylate Tablet Blister)

A single sheet of multiple small rectangular labels for Amlodipine Besylate 5 mg oral tablets. Each label includes the drug name, strength, a barcode, space for lot number and expiration date, and the labeler American Health Packaging in Columbus, Ohio.*

FDA Label Image

5 mg Amlodipine Besylate Tablets Carton (5 mg Amlodipine Besylate Tablets Carton)

Amlodipine Besylate Tablets, USP 5 mg oral tablets, packaged in bottles of 100 tablets (10 x 10) from American Health Packaging. The label includes the NDC number and dosing strength, with usage and storage instructions noted.*

FDA Label Image

8d812117 D273 B47b E053 2a95a90ad57b

Amlodipine Besylate oral tablets, white, round, with the imprint "209" on one side and a plain opposite side. Manufactured by American Health Packaging. Strength details are not visible on the tablet surface in this image.*

FDA Label Image

8d81521d 9e6c 1acf E053 2995a90a9242

Amlodipine Besylate oral tablet imprint 211, white, round, approximately 6 mm in diameter, showing front and back sides. The front side is embossed with the code 211; the back side is plain. This image corresponds to the Amlodipine Besylate tablet labeled by American Health Packaging available in strengths of 5 mg and 10 mg.*

FDA Label Image

8d81521d 9e6d 1acf E053 2995a90a9242

Amlodipine Besylate 10 mg oral tablet shown from front and back. The white, round tablet is embossed with the imprint '210' on one side; the other side is plain with no markings. The image depicts the tablet's physical appearance but does not include packaging or label information.*

FDA Label Image

Figure 1 -kaplan-meier Analysis Of Composite Clinical Outcomes For Amlodipine Versus Placebo (Amlodipine Gra)

A line graph depicting the event rate over time in months comparing Amlodipine to placebo. The graph shows two curves indicating a lower event rate for Amlodipine than placebo, with numerical data for number at risk along the x-axis and statistical values including a p-value of 0.003 and a hazard ratio of 0.691 with 95% confidence interval (0.54, 0.88).*

FDA Label Image

Amlodipine Structural Formula (Amlodipine Str 2)

Chemical structure diagram of amlodipine besylate showing its molecular framework, including aromatic rings and functional groups consistent with the active ingredient amlodipine besylate in tablet form.*

FDA Label Image

Figure 2 – Effects On Primary Endpoint Of Amlodipine Versus Placebo Across Sub-groups (Image 01)

A forest plot displaying hazard ratios with 95% confidence intervals comparing Amlodipine besylate to placebo across various patient subgroups, including overall population, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The horizontal axis represents hazard ratios from 0.0 to 2.0, with markers indicating favor toward Amlodipine or placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.